{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:53:53Z","timestamp":1719449633494},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T00:00:00Z","timestamp":1269561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00066-010-2090-9","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T05:34:31Z","timestamp":1269927271000},"page":"191-196","source":"Crossref","is-referenced-by-count":16,"title":["Nodal Follicular Lymphoma"],"prefix":"10.1007","volume":"186","author":[{"given":"Frank","family":"Heinzelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hellmut","family":"Ottinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,26]]},"reference":[{"key":"2090_CR1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"J.O. Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998;16:2780\u201395.","journal-title":"J Clin Oncol"},{"key":"2090_CR2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/1097-0142(19950501)75:9<2361::AID-CNCR2820750928>3.0.CO;2-N","volume":"75","author":"P.C. Besa","year":"1995","unstructured":"Besa PC, McLaughlin PW, Cox JD, et al. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer 1995;75:2361\u20137.","journal-title":"Cancer"},{"key":"2090_CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0167-8140(84)80072-9","volume":"2","author":"P. Carde","year":"1984","unstructured":"Carde P, Burgers JM, van Glabbeke M, et al. Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975\u20131980 EORTC controlled lymphoma trial. Radiother Oncol 1984;2:301\u201312.","journal-title":"Radiother Oncol"},{"key":"2090_CR4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0959-8049(95)00607-9","volume":"32A","author":"J.W. Denham","year":"1996","unstructured":"Denham JW, Denham E, Dear KB, et al. The follicular non-Hodgkin's lymphomas. I. The possibility of cure. Eur J Cancer 1996;32A:470\u20139.","journal-title":"Eur J Cancer"},{"key":"2090_CR5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00066-009-1937-4","volume":"185","author":"H.T. Eich","year":"2009","unstructured":"Eich HT, Heimann M, Stutzer H, et al. Long-term outcome and prognostic factors in early-stage nodal low-grade non-Hodgkin's lymphomas treated with radiation therapy. Strahlenther Onkol 2009;185:288\u201395.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00066-007-2007-4","volume":"183","author":"H.T. Eich","year":"2007","unstructured":"Eich HT, Muller RP. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma. Strahlenther Onkol 2007;183:16\u20138.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00066-008-1882-7","volume":"184","author":"H.T. Eich","year":"2008","unstructured":"Eich HT, Muller RP, Engenhart-Cabillic R, et al. Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 2008;184:406\u201310.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR8","first-page":"66","volume":"168","author":"R. Epelbaum","year":"1992","unstructured":"Epelbaum R, Kuten A, Coachman NM, et al. Stage I\u2013II low grade non-Hodgkin's lymphoma: prognostic factors and treatment results. Strahlenther Onkol 1992;168:66\u201372.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/108.3.675","volume":"108","author":"Z. Fuks","year":"1973","unstructured":"Fuks Z, Kaplan HS. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 1973;108:675\u201384.","journal-title":"Radiology"},{"key":"2090_CR10","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/1097-0142(197606)37:6<2806::AID-CNCR2820370636>3.0.CO;2-N","volume":"37","author":"E. Glatstein","year":"1976","unstructured":"Glatstein E, Fuks Z, Goffinet DR, et al. Non-Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 1976;37:2806\u201312.","journal-title":"Cancer"},{"key":"2090_CR11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0360-3016(84)90028-2","volume":"10","author":"M.K. Gospodarowicz","year":"1984","unstructured":"Gospodarowicz MK, Bush RS, Brown TC, et al. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 1984;10:489\u201397.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"2090_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0360-3016(99)90155-4","volume":"45","author":"M.K. Gospodarowicz","year":"1999","unstructured":"Gospodarowicz MK, Lippuner T, Pintilie M, et al. Stage I and II follicular lymphoma: longterm outcome and pattern of failure following treatment with involved field radiation therapy alone. Int J Radiat Oncol Biol Phys 1999;45(Suppl):217:abstract 137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/00313020500370192","volume":"37","author":"A.E. Grulich","year":"2005","unstructured":"Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 2005;37:409\u201319.","journal-title":"Pathology"},{"key":"2090_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","volume":"64","author":"B.A. Guadagnolo","year":"2006","unstructured":"Guadagnolo BA, Li S, Neuberg D, et al. Long-term outcome and mortality trends in early-stage, grade 1\u20132 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006;64:928\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR15","first-page":"215","volume":"3","author":"C.S. Ha","year":"1997","unstructured":"Ha CS, Cabanillas F, Lee MS, et al. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I\u2013III follicular lymphoma: a preliminary report. Clin Cancer Res 1997;3:215\u20139.","journal-title":"Clin Cancer Res"},{"key":"2090_CR16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2005.01.027","volume":"63","author":"C.S. Ha","year":"2005","unstructured":"Ha CS, Cabanillas F, Lee MS, et al. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I\u2013III follicular lymphoma. Int J Radiat Oncol Biol Phys 2005;63:188\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0360-3016(03)00641-2","volume":"57","author":"C.S. Ha","year":"2003","unstructured":"Ha CS, Kong JS, McLaughlin P, et al. Stage III follicular lymphoma: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 2003;57:748\u201354.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR18","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"N.L. Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835\u201349.","journal-title":"J Clin Oncol"},{"key":"2090_CR19","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1200\/JCO.2006.06.4618","volume":"25","author":"M. Herold","year":"2007","unstructured":"Herold M, Haas A, Srock S, et al. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. J Clin Oncol 2007;25:1986\u201392.","journal-title":"J Clin Oncol"},{"key":"2090_CR20","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W. Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005;106:3725\u201332.","journal-title":"Blood"},{"key":"2090_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.1993.11.2.233","volume":"11","author":"J.P. Jacobs","year":"1993","unstructured":"Jacobs JP, Murray KJ, Schultz CJ, et al. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. J Clin Oncol 1993;11:233\u20138.","journal-title":"J Clin Oncol"},{"key":"2090_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0360-3016(99)00051-6","volume":"44","author":"S.S. Kamath","year":"1999","unstructured":"Kamath SS, Marcus RB Jr, Lynch JW, et al. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1999;44:563\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMoa041511","volume":"352","author":"M.S. Kaminski","year":"2005","unstructured":"Kaminski MS, Tuck M, Estes J, et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 2005;352:441\u20139.","journal-title":"N Engl J Med"},{"key":"2090_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02990087","volume":"11","author":"S.M. Kelsey","year":"1994","unstructured":"Kelsey SM, Newland AC, Hudson GV, et al. A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkin's lymphoma. Med Oncol 1994;11:19\u201325.","journal-title":"Med Oncol"},{"key":"2090_CR25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.2003.07.070","volume":"21","author":"M. Ladetto","year":"2003","unstructured":"Ladetto M, Drandi D, Compagno M, et al. PCR-detectable nonneoplastic Bcl-2\/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003;21:1398\u2013403.","journal-title":"J Clin Oncol"},{"key":"2090_CR26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1097-0142(197909)44:3<831::AID-CNCR2820440307>3.0.CO;2-S","volume":"44","author":"T.G. Landberg","year":"1979","unstructured":"Landberg TG, Hakansson LG, Moller TR, et al. CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas: preliminary results of a randomized study. Cancer 1979;44:831\u20138.","journal-title":"Cancer"},{"key":"2090_CR27","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960","volume":"91","author":"A. Lopez.Guillermo","year":"1998","unstructured":"Lopez.Guillermo A, Cabanillas F, McLaughlin P, et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood 1998;91:2955\u201360.","journal-title":"Blood"},{"key":"2090_CR28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","volume":"14","author":"M.P. MacManus","year":"1996","unstructured":"MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282\u201390.","journal-title":"J Clin Oncol"},{"key":"2090_CR29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2004-08-3175","volume":"105","author":"R. Marcus","year":"2005","unstructured":"Marcus R, Imrie K, Belch A, et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005;105:1417\u201323.","journal-title":"Blood"},{"key":"2090_CR30","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/1097-0142(19861015)58:8<1596::AID-CNCR2820580803>3.0.CO;2-G","volume":"58","author":"P. McLaughlin","year":"1986","unstructured":"McLaughlin P, Fuller LM, Velasquez WS, et al. Stage I\u2013II follicular lymphoma. Treatment results for 76 patients. Cancer 1986;58:1596\u2013602.","journal-title":"Cancer"},{"key":"2090_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0360-3016(80)90027-9","volume":"6","author":"S. Monfardini","year":"1980","unstructured":"Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I\u2013II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980;6:125\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(00)00780-X","volume":"49","author":"A.D. Murtha","year":"2001","unstructured":"Murtha AD, Rupnow BA, Hansosn J, et al. Long-term follow-up of patients with stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001;49:3\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00066-003-1025-0","volume":"179","author":"H. Neumann","year":"2003","unstructured":"Neumann H, Blanck H, Koch R, et al. [Follicle centre lymphoma: treatment results for stage I and II.] Strahlenther Onkol 2003;179:840\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M","volume":"52","author":"N.I. Nissen","year":"1983","unstructured":"Nissen NI, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I\u2013II non-Hodgkin's lymphomas. Cancer 1983;52:1\u20137.","journal-title":"Cancer"},{"key":"2090_CR35","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909\u201318.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"2090_CR36","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","volume":"99","author":"G. Ott","year":"2002","unstructured":"Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002;99:3806\u201312.","journal-title":"Blood"},{"key":"2090_CR37","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00066-003-1062-8","volume":"179","author":"O.J. Ott","year":"2003","unstructured":"Ott OJ, Rodel C, Gramatzki M, et al. Radiotherapy for stage I\u2013III nodal low-grade non-Hodgkin's lymphoma. Strahlenther Onkol 2003;179:694\u2013701.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR38","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y","volume":"52","author":"S.B. Paryani","year":"1983","unstructured":"Paryani SB, Hoppe RT, Cox RS, et al. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer 1983;52:2300\u20137.","journal-title":"Cancer"},{"key":"2090_CR39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1200\/JCO.1984.2.7.841","volume":"2","author":"S.B. Paryani","year":"1984","unstructured":"Paryani SB, Hoppe RT, Cox RS, et al. The role of radiation therapy in the management of stage III follicular lymphomas. J Clin Oncol 1984;2:841\u20138.","journal-title":"J Clin Oncol"},{"key":"2090_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-8140(95)01600-L","volume":"36","author":"S. Pendlebury","year":"1995","unstructured":"Pendlebury S, el Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol 1995;36:167\u201371.","journal-title":"Radiother Oncol"},{"key":"2090_CR41","doi-asserted-by":"crossref","unstructured":"Petersen PM, Gospodarowicz M, Tsang R, et al. Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol 2004;22:Suppl 14:abstract 6521.","DOI":"10.1200\/jco.2004.22.90140.6521"},{"key":"2090_CR42","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2006.05.8198","volume":"24","author":"O.W. Press","year":"2006","unstructured":"Press OW, Unger JM, Braziel RM, et al. Phase II trial of CHOP chemotherapy followed by tositumomab\/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911. J Clin Oncol 2006;24:4143\u20139.","journal-title":"J Clin Oncol"},{"key":"2090_CR43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2007.06545.x","volume":"137","author":"A. Pulsoni","year":"2007","unstructured":"Pulsoni A, Starza ID, Frattarelli N, et al. Stage I\/II follicular lymphoma: spread of bcl-2\/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy. Br J Haematol 2007;137:216\u201320.","journal-title":"Br J Haematol"},{"key":"2090_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0360-3016(97)00722-0","volume":"40","author":"P.M. Richaud","year":"1998","unstructured":"Richaud PM, Soubeyran P, Eghbali H, et al. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study. Int J Radiat Oncol Biol Phys 1998;40:387\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00066-008-1772-z","volume":"184","author":"N. Rochet","year":"2008","unstructured":"Rochet N, Sterzing F, Jensen A, et al. Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol 2008;184:145\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR46","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood-2008-04-153189","volume":"112","author":"G. Salles","year":"2008","unstructured":"Salles G, Mounier N, de Guibert S, et al. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood 2008;112:4824\u201331.","journal-title":"Blood"},{"key":"2090_CR47","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","volume":"21","author":"J.F. Seymour","year":"2003","unstructured":"Seymour JF, Pro B, Fuller LM, et al. Long-term follow-up of a prospective study of combined modality therapy for stage I\u2013II indolent non-Hodgkin's lymphoma. J Clin Oncol 2003;21:2115\u201322.","journal-title":"J Clin Oncol"},{"key":"2090_CR48","doi-asserted-by":"crossref","unstructured":"Specht L. Primary radiotherapy of localised indolent non-Hodgkin's lymphoma. Radiother Oncol 2002;64(Suppl 1):abstract 7a.","DOI":"10.1016\/S0167-8140(02)82339-8"},{"key":"2090_CR49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00066-008-1778-6","volume":"184","author":"F. Sterzing","year":"2008","unstructured":"Sterzing F, Schubert K, Sroka-Perez G, et al. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg. Strahlenther Onkol 2008;184:8\u201314.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-007-1663-8","volume":"183","author":"G. Studer","year":"2007","unstructured":"Studer G, Luetolf UM, Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol 2007;183:417\u201323, discussion 424-5.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR51","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2273::AID-CNCR9>3.0.CO;2-V","volume":"80","author":"M. Stuschke","year":"1997","unstructured":"Stuschke M, Hoederath A, Sack H, et al. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-fruhe Stadien. Cancer 1997;80:2273\u201384.","journal-title":"Cancer"},{"key":"2090_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-8140(85)80086-4","volume":"4","author":"S.B. Sutcliffe","year":"1985","unstructured":"Sutcliffe SB, Gospodarowicz MK, Bush RS, et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985;4:211\u201323.","journal-title":"Radiother Oncol"},{"key":"2090_CR53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2007.02.006","volume":"17","author":"R.W. Tsang","year":"2007","unstructured":"Tsang RW, Gospodarowicz MK. Low-grade non-Hodgkin lymphomas. Semin Radiat Oncol 2007;17:198\u2013205.","journal-title":"Semin Radiat Oncol"},{"key":"2090_CR54","first-page":"1713","volume-title":"Clinical radiation oncology","author":"R.W. Tsang","year":"2007","unstructured":"Tsang RW, Gospodarowicz MK. Non-Hodgkin's lymphoma. In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. Philadelphia: Elsevier Churchill Livingstone, 2007:1713\u201351."},{"key":"2090_CR55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0360-3016(01)02701-8","volume":"52","author":"R.W. Tsang","year":"2002","unstructured":"Tsang RW, Gospodarowicz MK, O'sullivan B. Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology. Int J Radiat Oncol Biol Phys 2002;52:643\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.1994.213","volume":"69","author":"B. Vaughan Hudson","year":"1994","unstructured":"Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, et al. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994;69:1088\u201393.","journal-title":"Br J Cancer"},{"key":"2090_CR57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00066-008-1836-0","volume":"184","author":"M. Voordeckers","year":"2008","unstructured":"Voordeckers M, Everaert H, Tournel K, et al. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer. Strahlenther Onkol 2008;184:400\u20135.","journal-title":"Strahlenther Onkol"},{"key":"2090_CR58","unstructured":"Voss NJS, Klasa RJ, Fairey RN. The treatment of early stage, low grade non-Hodgkin's lymphoma with involved-field region irradiation. The BCCA experience. Ann Hematol 2001;80(Suppl 3):abstract B153."},{"key":"2090_CR59","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","volume":"51","author":"R.B. Wilder","year":"2001","unstructured":"Wilder RB, Jones D, Tucker SL, et al. Long-term results with radiotherapy for stage I\u2013II follicular lymphomas. Int J Radiat Oncol Biol Phys 2001;51:1219\u201327.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2090_CR60","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I","volume":"71","author":"J. Yahalom","year":"1993","unstructured":"Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer 1993;71:2342\u201350.","journal-title":"Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2090-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-010-2090-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-010-2090-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T10:39:31Z","timestamp":1591180771000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-010-2090-9"}},"subtitle":["The Role of Radiotherapy for Stages I and II"],"short-title":[],"issued":{"date-parts":[[2010,3,26]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s00066-010-2090-9","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,26]]}}}